March 13, 2025
Estimated Effectiveness of Nirsevimab Against Respiratory Syncytial Virus | Risk of Post-Acute Sequelae of COVID-19 and Oral Antivirals in Adults Aged Over 60 years: A Nationwide Retrospective Cohort Study
Estimated Effectiveness of Nirsevimab Against Respiratory Syncytial Virus | Risk of Post-Acute Sequelae of COVID-19 and Oral Antivirals in Adults Aged Over 60 years: A Nationwide Retrospective Cohort Study
Interim Estimates of 2024–2025 COVID-19 Vaccine Effectiveness Among Adults Aged ≥18 Years — VISION and IVY Networks, September 2024–January 2025 | Effect of Early and Delayed Treatment with Remdesivir on Mortality in Patients Hospitalized With COVID-19
Effectiveness of the Original Monovalent Messenger RNA Coronavirus Disease 2019 (COVID-19) Vaccination Series Against Hospitalization for COVID-19–Associated Venous Thromboembolism | Demographic Variation in U.S. Outpatient Hydroxychloroquine and Ivermectin Use During the COVID-19 Pandemic. | COVID-19 Vaccination and Odds of Post–COVID-19 Condition Symptoms in Children Aged 5 to 17 Years
COVID-19 Case Fatality Rate and Infection Fatality Rate from 2020 to 2023: Nationwide Analysis in Austria |
A Randomized, Double-blind, Phase 1, Single- and Multiple-dose Placebo-controlled Study of the Safety and Pharmacokinetics of IN-006, an Inhaled Antibody Treatment for COVID-19 in Healthy Volunteers |
Ensitrelvir for the Treatment of Nonhospitalized Adults with COVID-19
Despommier spent 38 years as a professor of microbiology and public health in environmental health
sciences at Columbia University, where he won the Best Teacher Award six times.
PWB Mourns Loss of Founder Dickson D. Despommier Read More »
Ten-Year Surveillance of RSV Hospitalizations in Adults: Incidence Rates and Case Definition Implications | Long-COVID Incidence Proportion in Adults and Children Between 2020 and 2024 | Effect of SARS-CoV-2 Infection on Sperm Telomere Length | Pediatric Gastrointestinal Tract Outcomes During the Postacute Phase of COVID-19
Co-infection of SARS‐CoV‐2 and Influenza A/B among Patients with COVID-19: A Systematic Review and Meta-analysis | Oseltamivir Reduces 30-Day Mortality in Older Adults with Influenza: A Pooled Analysis from the 2012-2019 Serious Outcomes Surveillance (SOS) Network of the Canadian Immunization Research Network (CIRN)
Parasites Without Borders is on a mission to make educational to provide free science education to all in an effort to eliminate human suffering from parasitic infections around the world.
Free Resources on Infectious and Parasitic Diseases Read More »
Respiratory Syncytial Virus Vaccine Effectiveness among U.S. Veterans |
Transcutaneous Vagus Nerve Stimulation Improves Long COVID Symptoms in a Female Cohort |
Distinct Pro-inflammatory/Pro-angiogenetic Signatures Distinguish Children |
Persistent Symptoms and Clinical Findings in Adults with Post-acute Sequelae of COVID-19 Syndrome |
Impact of COVID-19 Pandemic on the Incidence and Prevalence of Postural Orthostatic Tachycardia Syndrome
Comparative Effectiveness of Baloxavir Marboxil and Oseltamivir Treatment in Reducing Household Transmission of Influenza: A Post Hoc Analysis of the BLOCKSTONE Trial |
Host-microbe Multiomic Profiling Identifies Distinct COVID-19 Immune Dysregulation in Solid Organ Transplant Recipients |
Real‐world Effectiveness and Safety of Oral Azvudine versus Nirmatrelvir‒ritonavir (Paxlovid) in Hospitalized Patients with COVID-19: A Multicenter, Retrospective, Cohort Study
A comprehensive educational resource on all aspects of parasitic diseases and their impact on humanity around the globe.
Help bring the latest medical and basic biological information pertaining to diseases caused by eukaryotic parasites to every practicing physician and medical student within the United States.